Use of a human milk oligosaccharide (HMO), or a nutritional composition comprising a human milk oligosaccharide, to enhance executive function in a non-infant, to prevent and/or reduce the risk of sub-optimal executive function in a non-infant, to manage sub-optimal executive functioning in a non-infant, and/or to improve myelination to mature the pre-frontal cortex region of the brain in a non-infant, as well as synthetic compositions of HMOs and packs comprising at least 14 individual daily doses of an effective amount of at least one HMO for such a use.

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed.

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed.

The present invention relates to functional foods comprising DAO and their use for the prevention or treatment of diseases or pathological conditions associated with high levels of histamine in blood, in particular for the prevention or treatment of migraine, chronic fatigue, fibromyalgia, spondylitis and pain caused by muscle contractures.

The present invention relates to functional foods comprising DAO and their use for the prevention or treatment of diseases or pathological conditions associated with high levels of histamine in blood, in particular for the prevention or treatment of migraine, chronic fatigue, fibromyalgia, spondylitis and pain caused by muscle contractures.

A composition comprising Lactobacillus plantarum for preventing and/or treating mental illness, symptoms affecting mental health and/or conditions associated with chronic stress in a mammal is disclosed. The composition can be used in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of a dietary and food supplement and a medicament.

A composition comprising Lactobacillus plantarum for preventing and/or treating mental illness, symptoms affecting mental health and/or conditions associated with chronic stress in a mammal is disclosed. The composition can be used in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of a dietary and food supplement and a medicament.

The invention relates to a non-therapeutic method of improving or maintaining cognitive functioning in a subject, the method comprising administering to the subject a composition comprising subtilisin A hydrolysate of lysozyme. Furthermore, the invention relates to a subtilisin A hydrolysate of lysozyme for use in a method for the treatment of impaired cognitive functioning in a subject in need thereof. In addition, the invention relates to the use of a nutraceutical, a food product, a functional food, a food stuff, a food ingredient, a food supplement and/or a feed product, comprising a subtilisin A hydrolysate of lysozyme, in the non-therapeutic method of improving or maintaining cognitive functioning in a subject, or a nutraceutical, a food product, a functional food, a food stuff, a food ingredient, a food supplement and/or a feed product, comprising a subtilisin A hydrolysate of lysozyme, for use in the method for the treatment of impaired cognitive functioning in a subject in need thereof.

The invention relates to a non-therapeutic method of improving or maintaining cognitive functioning in a subject, the method comprising administering to the subject a composition comprising subtilisin A hydrolysate of lysozyme. Furthermore, the invention relates to a subtilisin A hydrolysate of lysozyme for use in a method for the treatment of impaired cognitive functioning in a subject in need thereof. In addition, the invention relates to the use of a nutraceutical, a food product, a functional food, a food stuff, a food ingredient, a food supplement and/or a feed product, comprising a subtilisin A hydrolysate of lysozyme, in the non-therapeutic method of improving or maintaining cognitive functioning in a subject, or a nutraceutical, a food product, a functional food, a food stuff, a food ingredient, a food supplement and/or a feed product, comprising a subtilisin A hydrolysate of lysozyme, for use in the method for the treatment of impaired cognitive functioning in a subject in need thereof.

A method for producing black ginseng concentrate is characterized by including steps of adding red ginseng to a continuous steaming-dryer followed by steaming, cooling, and drying to prepare black ginseng, carrying out extraction by adding alcohol to crushed black ginseng obtained by crushing the black ginseng prepared above followed by filtration to prepare black ginseng extract, and concentrating the black ginseng extract prepared above by using a plate type evaporative concentrator followed by heat treatment, and the present invention also relates to black ginseng concentrate prepared by the aforementioned method.